Seuraa
Oscar Arrieta
Oscar Arrieta
Head of the Thoracic Oncology Unit, Instituto Nacional de Cancerología de Mexico
Vahvistettu sähköpostiosoite verkkotunnuksessa unam.mx - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer
H Borghaei, L Paz-Ares, L Horn, DR Spigel, M Steins, NE Ready, ...
New England Journal of Medicine 373 (17), 1627-1639, 2015
95722015
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Lancet 373 (9674), 1525-1531, 2009
18092009
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy …
EB Garon, TE Ciuleanu, O Arrieta, K Prabhash, KN Syrigos, T Goksel, ...
The Lancet 384 (9944), 665-673, 2014
13782014
Nivolumab versus docetaxel in previously treated patients with advanced non–small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials …
L Horn, DR Spigel, EE Vokes, E Holgado, N Ready, M Steins, ...
Journal of clinical oncology 35 (35), 3924, 2017
8522017
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
EE Vokes, N Ready, E Felip, L Horn, MA Burgio, SJ Antonia, OA Frontera, ...
Annals of oncology 29 (4), 959-965, 2018
4592018
Five-year outcomes from the randomized, phase III trials checkmate 017 and 057: nivolumab versus docetaxel in previously treated non–small-cell lung cancer
H Borghaei, S Gettinger, EE Vokes, LQM Chow, MA Burgio, ...
Journal of Clinical Oncology 39 (7), 723, 2021
4152021
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin …
O Arrieta, RM Michel Ortega, G Villanueva-Rodríguez, MG Serna-Thomé, ...
BMC cancer 10, 1-7, 2010
3622010
Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer
Ó Arrieta, LP Angulo, C Núñez-Valencia, Y Dorantes-Gallareta, ...
Annals of surgical oncology 20, 1941-1948, 2013
3442013
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M Candelaria, D Gallardo-Rincón, C Arce, L Cetina, JL Aguilar-Ponce, ...
Annals of Oncology 18 (9), 1529-1538, 2007
2962007
Triple‐negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity
F Lara‐Medina, V Pérez‐Sánchez, D Saavedra‐Pérez, M Blake‐Cerda, ...
Cancer 117 (16), 3658-3669, 2011
2932011
Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised …
K Sánchez-Lara, JG Turcott, E Juárez-Hernández, C Nuñez-Valencia, ...
Clinical nutrition 33 (6), 1017-1023, 2014
2482014
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
N van Es, M Di Nisio, G Cesarman, A Kleinjan, HM Otten, I Mahé, IT Wilts, ...
haematologica 102 (9), 1494, 2017
2192017
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
ASCO Annual Meeting Proceedings J Clin Oncol 33, 2015 (suppl; abstr LBA109 …, 0
214*
Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
O Arrieta, AF Cardona, C Martín, L Más-López, L Corrales-Rodríguez, ...
Journal of Thoracic Oncology 10 (5), 838-843, 2015
2032015
Radiation-induced lung injury: current evidence
M Arroyo-Hernández, F Maldonado, F Lozano-Ruiz, W Muñoz-Montaño, ...
BMC pulmonary medicine 21, 1-12, 2021
1842021
Lung cancer in never smokers: The role of different risk factors other than tobacco smoking
L Corrales, R Rosell, AF Cardona, C Martin, ZL Zatarain-Barron, O Arrieta
Critical reviews in oncology/hematology 148, 102895, 2020
1842020
Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small …
K Sánchez-Lara, JG Turcott, E Juárez, P Guevara, C Núñez-Valencia, ...
Nutrition and cancer 64 (4), 526-534, 2012
1842012
Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis
O Arrieta, D Saavedra-Perez, R Kuri, A Aviles-Salas, L Martinez, ...
BMC cancer 9, 1-9, 2009
1822009
Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer
E Escobar, TS Rodriguez-Reyna, O Arrieta, J Sotelo
Current vascular pharmacology 2 (4), 385-399, 2004
1802004
The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
O Arrieta, B Cacho, D Morales-Espinosa, A Ruelas-Villavicencio, ...
BMC cancer 7, 1-9, 2007
1792007
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20